MLND Stock Price Falls Over 10% Pre-Market: Why It Happened
Tempest Therapeutics To Go Public Via Millendo Therapeutics Merger
Millendo Therapeutics (NASDAQ:MLND) Cut to “Hold” at Zacks Investment Research
Zacks Investment Research Upgrades Millendo Therapeutics (NASDAQ:MLND) to Buy
Millendo Therapeutics Inc (NASDAQ:MLND) Sees Significant Increase in Short Interest
Millendo Therapeutics (NASDAQ:MLND) Trading Down 3.8%
Millendo Therapeutics (NASDAQ:MLND) Shares Gap Down to $2.71
Leonardo books first-quarter loss, braces for higher virus impact in second quarter
GBP/CHF Continuation
USD/CAD Continuation
GBP/USD Continuation
What Are The Best Penny Stocks To Watch This Week? 3 For Your List
Millendo’s Julia Owens on leadership in rare diseases -